We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+23.34%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$509M
AUM Growth
+$16.9M
Cap. Flow
-$34.9M
Cap. Flow %
-6.86%
Top 10 Hldgs %
30.28%
Holding
101
New
29
Increased
19
Reduced
23
Closed
24

Top Buys

Rank Stock Value
1
KMX icon
CarMax
KMX
+$11.7M
2
DIS icon
Walt Disney
DIS
+$8.09M
3
BYND icon
Beyond Meat
BYND
+$7.92M
4
HEI.A icon
HEICO Corp Class A
HEI.A
+$7.1M
5
SAGE
Sage Therapeutics
SAGE
+$6.57M

Top Sells

Rank Stock Value
1
MSGS icon
Madison Square Garden
MSGS
+$6.89M
2
ZEN
ZENDESK INC
ZEN
+$6.12M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$4.78M
4
BA icon
Boeing
BA
+$4.58M
5
ASH icon
Ashland
ASH
+$4.56M

Sector Composition

Rank Sector Weight
1 Healthcare 32.67%
2 Technology 20.5%
3 Communication Services 11.6%
4 Consumer Discretionary 11.08%
5 Materials 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLK
76
PUT
DELISTED
Allakos
ALLK
$975K 0.19%
+22,500
New +$923K
MDCO
77
CALL
DELISTED
Medicines Co
MDCO
$806K 0.16%
22,100
+6,900
+45% +$225K
AAPL icon
78
PUT
Apple
AAPL
$4.48T
– –
-360,000
Closed -$17.1M
BA icon
79
Boeing
BA
$184B
– –
-12,000
Closed -$4.58M
BMRN icon
80
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-34,500
Closed -$3.06M
EFA icon
81
PUT
iShares MSCI EAFE ETF
EFA
$78.4B
– –
-200,000
Closed -$13M
FOLD
82
DELISTED
Amicus Therapeutics
FOLD
– –
-165,000
Closed -$2.24M
LITE icon
83
PUT
Lumentum
LITE
$60.6B
– –
-90,000
Closed -$5.09M
MSGS icon
84
Madison Square Garden
MSGS
$9.33B
– –
-32,947
Closed -$6.89M
NBIX icon
85
CALL
Neurocrine Biosciences
NBIX
$16.9B
– –
-70,000
Closed -$6.17M
NTNX icon
86
Nutanix
NTNX
$16.5B
– –
-22,000
Closed -$831K
PEN icon
87
Penumbra
PEN
$12.7B
– –
-24,000
Closed -$3.53M
RCKT icon
88
CALL
Rocket Pharmaceuticals
RCKT
$375M
– –
-125,000
Closed -$2.19M
RMD icon
89
PUT
ResMed
RMD
$31.3B
– –
-80,000
Closed -$8.32M
SAGE
90
CALL
DELISTED
Sage Therapeutics
SAGE
– –
-52,500
Closed -$8.35M
SPOT icon
91
Spotify
SPOT
$101B
– –
-18,100
Closed -$2.51M
TDOC icon
92
Teladoc Health
TDOC
$1.21B
– –
-59,000
Closed -$3.28M
UNH icon
93
UnitedHealth
UNH
$378B
– –
-5,500
Closed -$1.36M
VNDA icon
94
Vanda Pharmaceuticals
VNDA
$311M
– –
-141,000
Closed -$2.59M
VRTX icon
95
Vertex Pharmaceuticals
VRTX
$120B
– –
-26,000
Closed -$4.78M
NVTA
96
DELISTED
Invitae Corporation
NVTA
– –
-185,000
Closed -$4.33M
FTCH
97
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
– –
-130,000
Closed -$3.5M
DBD
98
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
– –
-100,000
Closed -$1.11M
ZEN
99
DELISTED
ZENDESK INC
ZEN
– –
-72,000
Closed -$6.12M
AERI
100
DELISTED
Aerie Pharmaceuticals
AERI
– –
-65,000
Closed -$3.09M
1 2 3
4
5

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Atika Capital Management held 101 positions worth $509M, up 3.4% from $492M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Atika Capital Management withdrew a net $34.9M in Q2 2019, closing 24 positions and reducing 23 holdings. Its most notable exit was Madison Square Garden, an estimated $6.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 29% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Atika Capital Management opened a new position in CarMax worth $13M.

  • Atika Capital Management's largest Q2 2019 buy was CarMax: 150,000 shares worth $13M.
  • Atika Capital Management added most to Martin Marietta Materials in Q2 2019, an estimated $3.03M increase.
  • Atika Capital Management's biggest Q2 2019 reduction was Ashland, cutting an estimated $4.56M.
  • Atika Capital Management fully exited Madison Square Garden in Q2 2019, selling an estimated $6.89M.
  • Atika Capital Management's ten largest holdings make up 30% of its $509M portfolio in Q2 2019.
  • Atika Capital Management opened 29 new positions and closed 24 in Q2 2019.
  • Atika Capital Management's portfolio value rose 3.4% quarter-over-quarter to $509M.

Based on Atika Capital Management's 13F filing for Q2 2019, filed 12 Aug 2019.